Table of Contents
X-Ray Optics and Instrumentation
Volume 2008 (2008), Article ID 709692, 17 pages
http://dx.doi.org/10.1155/2008/709692
Research Article

High-Definition X-Ray Fluorescence: Applications

X-Ray Optical Systems, Inc. 15 Tech Valley Drive, East Greenbush, NY 12061, USA

Received 5 March 2008; Accepted 14 July 2008

Academic Editor: Ladislav Pina

Copyright © 2008 Walter M. Gibson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z. W. Chen, W. M. Gibson, and H. Huang, “High definition X-ray fluorescence: principles and techniques,” X-Ray Optics and Instrumentation, vol. 2008, Article ID 318171, 10 pages, 2008. View at Publisher · View at Google Scholar
  2. J. Firket, “Fog along the Meuse Valle,” Transactions of the Faraday Society, vol. 32, pp. 1191–1194, 1936. View at Google Scholar
  3. W. P. D. Logan, “Mortality in the London fog incident, 1952,” The Lancet, vol. 261, no. 6755, pp. 336–338, 1953. View at Publisher · View at Google Scholar
  4. A. Ciocco and D. J. Thompson, “A follow-up of Donora ten years after: methodology and findings,” American Journal of Public Health and the Nation's Health, vol. 51, no. 2, pp. 155–164, 1961. View at Google Scholar
  5. D. V. Bates, “Health indices of the adverse effects of air pollution: the question of coherence,” Environmental Research, vol. 59, no. 2, pp. 336–349, 1992. View at Publisher · View at Google Scholar
  6. R. Bascom, P. A. Bromberg, D. A. Costa et al., “Health effects of outdoor air pollution,” American Journal of Respiratory and Critical Care Medicine, vol. 153, no. 1, pp. 3–50, 1996. View at Google Scholar
  7. U.S. Environmental Protection Agency, “National Ambient Air Quality Standards for Particulate Matter,” Federal Register, vol. 62, no. 138, pp. 38651–38760, 1997. View at Google Scholar
  8. CDC, report on human exposure, 2005.
  9. Genes, Environment and Health Initiative (GEI), National Institutes of Health, Bethesda, Md, USA, http://www.gei.nih.gov/exposurebiology/index.asp.
  10. The National Children's Study, http://www.nationalchildrensstudy.gov/.
  11. Research Triangle Institute, North Carolina, private communication.
  12. P.J. Parsons, “Atomic spectroscopy in clinical chemistry,” in Encyclopedia of Analytical Chemistry, R.A. Myers, Ed., pp. 1091–1123, John Wiley and Sons Ltd., Chichester, 2000.
  13. L.M. Sayre, G. Perry, C.S. Attwood,, and M.A. Smith, “The role of metals in neurodegenative diseases,” Cellular and Molecular Biology, vol. 46, no. 4, pp. 731–741, 2000. View at Google Scholar
  14. R.N. Rosenbeg, “The molecular and genetic basis of AD: the end of the beginning: the 2000 Warttenberg Lecture,” Neurology, vol. 54, pp. 2045–2054, 2000. View at Google Scholar
  15. A. Ala, A.P. Walker, K. Ashkan, J.S. Dooley, and M.L. Schilsky, “Wilson's disease,” Lancet, vol. 369, no. 9559, 2007. View at Publisher · View at Google Scholar
  16. A. Pietrangelo, “Hereditary hemochromatosis-a new look at an old disease,” New England Journal of Medicine, vol. 350, no. 23, pp. 2383–2397, 2004. View at Google Scholar
  17. B.P. Lanphear, R. Hornung, J. Khoury et al., “Low-level environmental lead exposure and children's intellectual function: an international pooled analysis,” Environmental Health Perspective, vol. 113, no. 7, pp. 894–899, 2005. View at Google Scholar
  18. W.R. Chappell, Jr, C.O. Abernathy, R.I. Calderon et al., “Arsenic Exposure and Health Effects,” , Ed., Elsevier, Amsterdam, The Netherlands, 1999.
  19. J. Burger, A. Stern, and M. Gochfeld, Eds., “Mercury in commercial fiash: optimizing individual choices to reduce risk,” Environmental Health Perspectives, vol. 113, no. 3, pp. 266–271, 2005. View at Google Scholar
  20. M.J. Schroder, “Cadmium,” in Experimental and Clinical Neurotoxicology, P. S. Spencer and H.H. Schaumberg, Eds., pp. 276–280, 2nd Edition edition, 2000, Oxford University Press, NY, USA, 2000. View at Google Scholar
  21. P. S. Spencer and H.H. Schaumberg, Eds., “Experimental and Clinical Neurotoxicology,” P. S. Spencer and H.H. Schaumberg, Eds., 2nd Edition edition, Oxford University Press, NY, USA, 2000.
  22. L. Goodman, “Alzheimer's disease—a clinicopathologic analysis of 23 cases with a theory on pathogenisis,” The Journal of Nervous and Mental Disease, vol. 118, pp. 97–130, 1953. View at Google Scholar
  23. D. P. Perl and P. F. Good, “Comparative techniques for determining cellular iron distribution in brain tissues,” Annals of Neurology, vol. 32, no. S1, pp. S76–S81, 2004. View at Publisher · View at Google Scholar
  24. C. M. Morris, J. M. Candy, A. E. Oakley, C. A. Bloxham, and J. A. Edwardson, “Histochemical distribution of non-haem iron in the human brain,” Acta Anatomica, vol. 144, no. 3, pp. 235–257, 1992. View at Publisher · View at Google Scholar
  25. L. M. Sayre, G. Perry, P. L. R. Harris, Y. Liu, K. A. Schubert, and M. A. Smith, “In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals,” Journal of Neurochemistry, vol. 74, no. 1, pp. 270–279, 2000. View at Publisher · View at Google Scholar
  26. J. F. Schenck and E. A. Zimmerman, “High-field magnetic resonance imaging of brain iron: birth of a biomarker?,” NMR in Biomedicine, vol. 17, no. 7, pp. 433–445, 2004. View at Publisher · View at Google Scholar · View at PubMed
  27. E. M. Haacke, N. Y. C. Cheng, M. J. House et al., “Imaging iron stores in the brain using magnetic resonance imaging,” Magnetic Resonance Imaging, vol. 23, no. 1, pp. 1–25, 2005. View at Publisher · View at Google Scholar · View at PubMed
  28. L. M. Miller, Q. Wang, T. P. Telivala, R. J. Smith, A. Lanzirotti, and J. Miklossy, “Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with β-amyloid deposits in Alzheimer's disease,” Journal of Structural Biology, vol. 155, no. 1, pp. 30–37, 2006. View at Publisher · View at Google Scholar · View at PubMed
  29. A. Mikhaylova, M. Davidson, H. Toastmann et al., “Detection, identification and mapping of iron anomalies in brain tissue using X-ray absorption spectroscopy,” Journal of the Royal Society Interface, vol. 2, no. 2, pp. 33–37, 2005. View at Publisher · View at Google Scholar · View at PubMed
  30. J. F. Collingwood, A. Mikhaylova, M. Davidson et al., “In situ characterization and mapping of iron compounds in Alzheimer's disease tissue,” Journal of Alzheimer's Disease, vol. 7, no. 4, pp. 267–272, 2005. View at Google Scholar
  31. J. F. Collingwood, A. Mikhaylova, M. R. Daavidson et al., “High-resolution X-ray absorption spectroscopy studies of metal compounds in neurodegenerative brain tissue,” Journal of Physics: Conference Series, vol. 17, pp. 54–60, 2005. View at Publisher · View at Google Scholar
  32. J. Collingwood and J. Dobson, “Mapping and characterization of iron compounds in Alzheimer's tissue,” Journal of Alzheimer's Disease, vol. 10, no. 2-3, pp. 215–222, 2006. View at Google Scholar
  33. A. Ide-Ektessabi, T. Kawakami, and F. Watt, “Distribution and chemical state analysis of iron in the Parkinsonian substantia nigra using synchrotron radiation micro beams,” Nuclear Instruments and Methods in Physics Research Section B, vol. 213, pp. 590–594, 2004. View at Publisher · View at Google Scholar
  34. D. J. Bellis, Z. Chen, W. M. Gibson, and P. J. Parsons, “Element distribution in bone measured by focused monochromatic microbeam X-ray fluorescence with a low-power source coupled to doubly curved crystal optics,” submitted to Journal of Analytical Atomic Spectrometry.